Cargando…
Dysregulation of Insulin-Linked Metabolic Pathways in Alzheimer’s Disease: Co-Factor Role of Apolipoprotein E ɛ4
BACKGROUND: Brain insulin resistance and deficiency are well-recognized abnormalities in Alzheimer’s disease (AD) and likely mediators of impaired energy metabolism. Since apolipoprotein E (APOE) is a major risk factor for late-onset AD, it was of interest to examine its potential contribution to al...
Autores principales: | Robbins, James, Busquets, Oriol, Tong, Ming, de la Monte, Suzanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739986/ https://www.ncbi.nlm.nih.gov/pubmed/33344887 http://dx.doi.org/10.3233/ADR-200238 |
Ejemplares similares
-
Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways
por: Liou, Connie J., et al.
Publicado: (2019) -
Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-ε4–associated Alzheimer's disease
por: Delikkaya, Büşra, et al.
Publicado: (2019) -
Apolipoprotein E and Alzheimer's disease
por: Troutwine, Benjamin R., et al.
Publicado: (2022) -
The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
por: Jendresen, Charlotte, et al.
Publicado: (2017) -
Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease
por: Liao, Fan, et al.
Publicado: (2017)